TS Nexgen Co., Ltd. (KOSDAQ:043220)
1,710.00
-720.00 (-29.63%)
At close: Mar 31, 2025
TS Nexgen Revenue
TS Nexgen had revenue of 2.02B KRW in the quarter ending June 30, 2026, a decrease of -46.89%. This brings the company's revenue in the last twelve months to 12.23B, down -36.85% year-over-year. In the year 2025, TS Nexgen had annual revenue of 14.54B, down -32.36%.
Revenue (ttm)
12.23B
Revenue Growth
-36.85%
P/S Ratio
2.23
Revenue / Employee
249.65M
Employees
49
Market Cap
27.23B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 14.54B | -6.95B | -32.36% |
| Dec 31, 2024 | 21.49B | -5.05B | -19.04% |
| Dec 31, 2023 | 26.55B | 1.04B | 4.09% |
| Dec 31, 2022 | 25.50B | 6.96B | 37.57% |
| Dec 31, 2021 | 18.54B | -4.22B | -18.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| GH Advanced Materials | 88.24B |
| Kwang Jin Ind. | 58.91B |
| Sungwoo Techron. Co,.Ltd | 45.84B |
| Wantedlab | 41.21B |
| Billions | 25.31B |
| Mason Capital | 21.95B |
| GFC Life Science | 19.24B |
| Kweather | 18.37B |